share_log

Even Though Jiangsu ChengXing Phosph-Chemicals (SHSE:600078) Has Lost CN¥371m Market Cap in Last 7 Days, Shareholders Are Still up 183% Over 3 Years

Even Though Jiangsu ChengXing Phosph-Chemicals (SHSE:600078) Has Lost CN¥371m Market Cap in Last 7 Days, Shareholders Are Still up 183% Over 3 Years

儘管江蘇誠行磷化工(SHSE:600078)在最近7天內市值下降了371萬元人民幣,但股東在過去3年中仍然獲得了183%的回報。
Simply Wall St ·  06/25 19:16

Jiangsu ChengXing Phosph-Chemicals Co., Ltd. (SHSE:600078) shareholders might be concerned after seeing the share price drop 16% in the last month. But in three years the returns have been great. In three years the stock price has launched 180% higher: a great result. It's not uncommon to see a share price retrace a bit, after a big gain. The thing to consider is whether the underlying business is doing well enough to support the current price.

江蘇橙信磷化工股份有限公司(SHSE:600078)的股東可能會感到擔憂,因爲股價在過去一個月中下跌了16%。但是,在三年內收益卻非常可觀,股價上漲了180%:非常棒的結果。在大漲之後看到股價有所回落並不少見。需要考慮的是基本業務是否足夠強大,能夠支持目前的價格。

While this past week has detracted from the company's three-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

儘管過去一週公司的三年回報率有所下降,但讓我們看看基礎業務的最近趨勢,以確定收益是否與之相符。

Given that Jiangsu ChengXing Phosph-Chemicals didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually desire strong revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

考慮到江蘇橙信磷化工在過去12個月內沒有盈利,我們將專注於營業收入增長,快速了解其業務發展。未盈利公司的股東通常希望營收增長強勁。這是因爲快速的營收增長往往可以被推斷爲具有相當大的盈利,很容易預測。

Over the last three years Jiangsu ChengXing Phosph-Chemicals has grown its revenue at 0.5% annually. Considering the company is losing money, we think that rate of revenue growth is uninspiring. In comparison, the share price rise of 41% per year over the last three years is pretty impressive. We'd need to take a closer look at the revenue and profit trends to see whether the improvements might justify that sort of increase. It may be that the market is pretty optimistic about Jiangsu ChengXing Phosph-Chemicals if you look to the bottom line.

在過去三年中,江蘇橙信磷化工的營收年平均增長率爲0.5%。考慮到公司正在虧損,我們認爲這種營收增長率並不令人振奮。相比之下,過去三年中每年增長41%的股價上漲幅度相當驚人。我們需要更仔細地觀察營收和利潤趨勢,以確定這種增長是否能夠證明這種上漲是有價值的。可能市場對江蘇橙信磷化工非常樂觀,如果看底線的話。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

你可以在下面的圖片中看到收入和營業收入隨時間的變化情況(單擊圖表可查看精確值)。

earnings-and-revenue-growth
SHSE:600078 Earnings and Revenue Growth June 25th 2024
SHSE:600078股票的盈利和營收增長情況於2024年6月25日

If you are thinking of buying or selling Jiangsu ChengXing Phosph-Chemicals stock, you should check out this FREE detailed report on its balance sheet.

如果您正在考慮買入或賣出江蘇橙信磷化工的股票,您應該查看這份關於其資產負債表的免費詳細報告。

What About Dividends?

那麼分紅怎麼樣呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Jiangsu ChengXing Phosph-Chemicals, it has a TSR of 183% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

在考慮投資回報時,重要的是考慮總股東回報(TSR)和股票回報之間的差異。 TSR包括任何剝離或折讓的資本籌集(基於股息被重新投資的假設),以及任何股息。因此,對於支付慷慨的股息公司而言,TSR通常比股票回報高得多。就中國神威藥業集團而言,其TSR在過去5年中達到了75%。這超過了我們之前提到的股票回報。該公司支付的股息已經提高了總股東回報。總股東回報股票回報儘管股價回報僅反映了股價的變化,但TSR包括股息(假設它們被再投資)的價值和任何打折資本籌集或剝離的利益。可以說,TSR爲股票的回報提供了更全面的圖片。在江蘇橙信磷化工的情況下,它在過去的三年中擁有183%的TSR。這超過了我們之前提到的股價回報。這很大程度上是由其分紅所帶來的成果!

A Different Perspective

不同的觀點

While the broader market lost about 14% in the twelve months, Jiangsu ChengXing Phosph-Chemicals shareholders did even worse, losing 32% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. On the bright side, long term shareholders have made money, with a gain of 10% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that Jiangsu ChengXing Phosph-Chemicals is showing 1 warning sign in our investment analysis , you should know about...

儘管股市在過去12個月中失去了約14%,江蘇橙信磷化工的股東表現得更差,失去了32%(包括股息),但有些股票在下跌的市場中被過度賣出是不可避免的。關鍵在於關注基本面的發展。從積極的一面來看,長期股東已經賺了錢,在過去的五年裏每年增長了10%。可能最近的拋售是一次機會,因此有必要檢查基本數據是否存在長期增長趨勢的跡象。我認爲查看股價是業務表現的一種代理方法非常有趣。但是爲了真正獲得見解,我們需要考慮其他信息。即便如此,要知道,在我們的投資分析中,江蘇橙信磷化工出現了一個警告信號。

If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.

如果您像我一樣,就不會希望錯過這份免費的內部人士正在購買的低估小市值股票列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,也可以發送電子郵件至editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論